HK1099203A1 - Piperidinyl prostaglandin e analogs - Google Patents

Piperidinyl prostaglandin e analogs

Info

Publication number
HK1099203A1
HK1099203A1 HK07105354A HK07105354A HK1099203A1 HK 1099203 A1 HK1099203 A1 HK 1099203A1 HK 07105354 A HK07105354 A HK 07105354A HK 07105354 A HK07105354 A HK 07105354A HK 1099203 A1 HK1099203 A1 HK 1099203A1
Authority
HK
Hong Kong
Prior art keywords
analogs
prostaglandin
piperidinyl
piperidinyl prostaglandin
Prior art date
Application number
HK07105354A
Other languages
English (en)
Inventor
David W Old
Danny T Dinh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HK1099203A1 publication Critical patent/HK1099203A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK07105354A 2004-01-22 2007-05-21 Piperidinyl prostaglandin e analogs HK1099203A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/763,702 US6977260B2 (en) 2004-01-22 2004-01-22 Piperidinyl prostaglandin E analogs
PCT/US2005/001461 WO2005072735A1 (en) 2004-01-22 2005-01-14 Piperidinyl prostaglandin e analogs

Publications (1)

Publication Number Publication Date
HK1099203A1 true HK1099203A1 (en) 2007-08-10

Family

ID=34795110

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07105354A HK1099203A1 (en) 2004-01-22 2007-05-21 Piperidinyl prostaglandin e analogs

Country Status (12)

Country Link
US (1) US6977260B2 (de)
EP (1) EP1722795B1 (de)
JP (1) JP4740883B2 (de)
AR (1) AR047436A1 (de)
AT (1) ATE394101T1 (de)
AU (1) AU2005209209B2 (de)
CA (1) CA2553387C (de)
DE (1) DE602005006534D1 (de)
ES (1) ES2303672T3 (de)
HK (1) HK1099203A1 (de)
TW (1) TWI348370B (de)
WO (1) WO2005072735A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease
EP1812017A2 (de) * 2004-10-21 2007-08-01 Duke University Ophthalmologische arzneimittel
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3220156C2 (de) * 1982-05-28 1990-01-25 Heida Houston Tex. Thurlow Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel
IT1225716B (it) * 1988-10-26 1990-11-22 Esacontrol Spa Dispositivo per la protezione dei rele' di binario dai disturbi elettrici
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
US5034413A (en) 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
DE4318713C1 (de) * 1993-06-07 1994-09-15 Daimler Benz Ag Zahnräderwechselgetriebe der Vorgelegebauart
ATE487514T1 (de) * 2002-06-06 2010-11-15 Merck Frosst Canada Ltd 1,5-disubstituierte pyrrolid-2-on-derivate zur verwendung als ep4 rezeptor agonisten zur behandlung von augenkrankheiten wie z.b. glaukom
US7053085B2 (en) 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
CA2511255C (en) 2003-01-10 2009-04-07 F. Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
BRPI0411057A (pt) * 2003-06-06 2006-07-25 Allergan Inc análogos de prostaglandina e de piperidinila
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs

Also Published As

Publication number Publication date
AU2005209209A1 (en) 2005-08-11
JP2007520489A (ja) 2007-07-26
TW200533350A (en) 2005-10-16
US20050164990A1 (en) 2005-07-28
EP1722795A1 (de) 2006-11-22
WO2005072735A1 (en) 2005-08-11
EP1722795B1 (de) 2008-05-07
ES2303672T3 (es) 2008-08-16
US6977260B2 (en) 2005-12-20
JP4740883B2 (ja) 2011-08-03
CA2553387C (en) 2013-04-02
ATE394101T1 (de) 2008-05-15
AU2005209209B2 (en) 2012-03-08
CA2553387A1 (en) 2005-08-11
TWI348370B (en) 2011-09-11
DE602005006534D1 (de) 2008-06-19
AR047436A1 (es) 2006-01-18

Similar Documents

Publication Publication Date Title
ZA200700357B (en) Tetrapetide analogs
ZA200605354B (en) Prostaglandin nitrooxyderivatives
IL209859A0 (en) Epitope analogs
HK1100667A1 (en) Constrained himbacine analogs as thrombin receptorantagonists
HK1114832A1 (en) 12-aryl prostaglandin analogs 12-
EP1845972A4 (de) Auf cannabinoid-rezeptoren einwirkende neuartige heteropyrrol-analoge
ZA200703022B (en) N-benzenesulfonyl substituted anilino-pyrimidine analogs
PL1776090T3 (pl) Stabilizowana kompozycja prostaglandyny
EP1718638A4 (de) Neue verbindungen
GB0400812D0 (en) Novel compounds
IL181857A0 (en) Quinolone analogs
EP1888618A4 (de) Analoga von glycyl-prolyl-glutamat
GB0402140D0 (en) Novel compounds
EP1610759A4 (de) Substituierte chinobenzoxazin-analoga
EP1805132A4 (de) Neue verbindungen
EP1796793A4 (de) Neue verbindungen
EP1810029A4 (de) Topiramat-analoga
GB0427403D0 (en) Novel compounds I
HK1099203A1 (en) Piperidinyl prostaglandin e analogs
GB0402355D0 (en) Novel compounds
GB0402134D0 (en) Novel compounds
GB0400699D0 (en) Novel compounds
GB0402144D0 (en) Novel compounds
GB0402115D0 (en) Novel compounds
GB0402114D0 (en) Novel compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150114